Insulin resistance in glomerular podocytes: Potential mechanisms of induction

Dorota Rogacka1

  • 1Mossakowski Medical Research Institute, Polish Academy of Sciences, Laboratory of Molecular and Cellular Nephrology, Wita Stwosza 63, 80-308, Gdansk, Poland; University of Gdansk, Faculty of Chemistry, Department of Molecular Biotechnology, Wita Stwosza 63, 80-308, Gdansk, Poland.

Insights

Nutrient overload causes insulin resistance in glomerular podocytes. This impairs glucose uptake by affecting pathways like NADPH oxidase, AMPK, and SIRT1, contributing to diabetic kidney disease.

Area of Science:

  • Nephrology
  • Cellular Biology
  • Metabolic Research

Background:

  • Glomerular podocytes are crucial for kidney filtration and respond to insulin.
  • Insulin resistance in podocytes disrupts glucose uptake, a key factor in diabetic nephropathy.
  • Nutrient overload is increasingly recognized as a driver of podocyte dysfunction.

Purpose of the Study:

  • To review the cellular and molecular mechanisms underlying insulin resistance in glomerular podocytes.
  • To highlight the impact of nutrient overload and diabetic environments on podocyte insulin signaling.
  • To consolidate current understanding of factors contributing to podocyte insulin resistance.

Main Methods:

  • Literature review of recent studies on podocyte insulin resistance.
  • Analysis of molecular pathways affected by high glucose and fatty acids.
  • Examination of signaling cascades including oxidative stress, AMPK, SIRT1, and calcium channels.

Main Results:

  • High glucose induces oxidative stress via NADPH oxidase, reduces AMPK phosphorylation, and decreases SIRT1 activity.
  • Calcium signaling through TRPC6 channels is implicated in regulating insulin sensitivity.
  • Elevated insulin and palmitic acid levels in a diabetic environment promote insulin receptor degradation and insulin resistance.

Conclusions:

  • Multiple cellular and molecular pathways contribute to insulin resistance in podocytes under conditions of nutrient overload and diabetes.
  • Understanding these mechanisms is vital for developing targeted therapies for diabetic kidney disease.
  • Podocyte insulin resistance represents a critical link between metabolic dysfunction and kidney damage.

Related Concept Videos

Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.8K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
1.6K
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
360
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
496
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
303
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
6.0K